Clinical Trials Browser

Phase 1 × Interleukin-12 × 1 year × Clear all

NCT03030378 2026-03-19

Pembrolizumab and Recombinant Interleukin-12 in Treating Patients With Solid Tumors

Phase 1 Active not recruiting

Neoplasm Metastasis

NCT02483312 2025-12-01

A Study of (Interleukin-12) IL-12 in Patients With Acute Myelogenous Leukemia (AML)

Phase 1 Active not recruiting

Other hematologic neoplasm

Recurrence, Leukemia, Myeloid, Acute